Literature DB >> 35380796

Transport of Maternally Administered Pharmaceutical Agents Across the Placental Barrier In Vitro.

Rajeendra L Pemathilaka1, Nima Alimoradi1, David E Reynolds1, Nicole N Hashemi1,2.   

Abstract

To understand the transport of pharmaceutical agents and their effects on developing fetus, we have created a placental microsystem that mimics structural phenotypes and physiological characteristic of a placental barrier. We have shown the formation of a continuous network of epithelial adherens junctions and endothelial cell-cell junctions confirming the integrity of the placental barrier. More importantly, the formation of elongated microvilli under dynamic flow condition is demonstrated. Fluid shear stress acts as a mechanical cue triggering the microvilli formation. Pharmaceutical agents were administered to the maternal channel, and the concentration of pharmaceutical agents in fetal channel for coculture and control models were evaluated. In fetal channel, the coculture model exhibited about 2.5 and 2.2% of the maternal initial concentration for naltrexone and 6β-naltrexol, respectively. In acellular model, fetal channel showed about 10.5 and 10.3% of the maternal initial concentration for naltrexone and 6β-naltrexol, respectively. Gene expressions of epithelial cells after direct administration of naltrexone and 6β-naltrexol to the maternal channel and endothelial cells after exposure due to transport through placental barrier are also reported.

Entities:  

Keywords:  6β-naltrexol; NTX; fluid shear stress; microfluidics; placental barrier; placenta-on-a-chip

Mesh:

Substances:

Year:  2022        PMID: 35380796      PMCID: PMC9116385          DOI: 10.1021/acsabm.2c00121

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  66 in total

1.  PDMS absorption of small molecules and consequences in microfluidic applications.

Authors:  Michael W Toepke; David J Beebe
Journal:  Lab Chip       Date:  2006-10-04       Impact factor: 6.799

2.  Trophoblast plugs: impact on utero-placental haemodynamics and spiral artery remodelling.

Authors:  Joanna L James; Rojan Saghian; Rebecca Perwick; Alys R Clark
Journal:  Hum Reprod       Date:  2018-08-01       Impact factor: 6.918

Review 3.  Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.

Authors:  Hendrée E Jones; Margaret S Chisolm; Lauren M Jansson; Mishka Terplan
Journal:  Addiction       Date:  2012-04-04       Impact factor: 6.526

4.  Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.

Authors:  David W Oslin; Shirley H Leong; Kevin G Lynch; Wade Berrettini; Charles P O'Brien; Adam J Gordon; Margaret Rukstalis
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

5.  Metabolism and disposition of naltrexone in man after oral and intravenous administration.

Authors:  M E Wall; D R Brine; M Perez-Reyes
Journal:  Drug Metab Dispos       Date:  1981 Jul-Aug       Impact factor: 3.922

6.  Three-dimensional paper-based microfluidic device for assays of protein and glucose in urine.

Authors:  Deidre Sechi; Brady Greer; Jesse Johnson; Nastaran Hashemi
Journal:  Anal Chem       Date:  2013-11-11       Impact factor: 6.986

7.  A microphysiological model of the human placental barrier.

Authors:  Cassidy Blundell; Emily R Tess; Ariana S R Schanzer; Christos Coutifaris; Emily J Su; Samuel Parry; Dongeun Huh
Journal:  Lab Chip       Date:  2016-08-02       Impact factor: 6.799

8.  Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.

Authors:  Shaunik Sharma; Steven Carlson; Sreekanth Puttachary; Souvarish Sarkar; Lucas Showman; Marson Putra; Anumantha G Kanthasamy; Thimmasettappa Thippeswamy
Journal:  Neurobiol Dis       Date:  2017-11-29       Impact factor: 5.996

Review 9.  Go with the Flow-Trophoblasts in Flow Culture.

Authors:  Beatrice A Brugger; Jacqueline Guettler; Martin Gauster
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.